Skip to content
healthcare.dev

benzethonium chloride 0.0015 MG/MG / diphenhydramine hydrochloride 0.02 MG/MG / zinc acetate 0.00215 MG/MG Topical Gel [Calagel]

RxNorm concept 1049176, branded drug (sbd). Prescribable name: Calagel 0.15 % / 2 % / 0.215 % Topical Gel.

RxCUI
1049176
Term type
Branded drug (SBD)
Status
Active
Request
curl https://api.healthcare.dev/v1/drugs/rxnorm/1049176 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

Other names

Calagel (benzethonium chloride 0.0015 MG/MG / diphenhydrAMINE hydrochloride 0.02 MG/MG / zinc acetate 0.00215 MG/MG) Topical Gel; Calagel (benzethonium chloride 0.0015 MG/MG / diphenhydramine hydrochloride 0.02 MG/MG / zinc acetate 0.00215 MG/MG) Topical Gel; Calagel (benzethonium chloride 0.15 % / diphenhydrAMINE hydrochloride 2 % / zinc acetate 0.215 % ) Topical Gel; Calagel (benzethonium chloride 0.15 % / diphenhydramine hydrochloride 2 % / zinc acetate 0.215 % ) Topical Gel; benzethonium chloride 0.0015 MG/MG / diphenhydrAMINE hydrochloride 0.02 MG/MG / zinc acetate 0.00215 MG/MG Topical Gel [Calagel]

Related concepts

Linked data

NDCs

  • 51879080006

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 1049176 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/rxnorm/1049176 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up RxNorm concept 1049176. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.